| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Filamin | 1.27e-04 | 11 | 29 | 2 | PF00630 | |
| Domain | Filamin/ABP280_rpt | 1.27e-04 | 11 | 29 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.27e-04 | 11 | 29 | 2 | IPR017868 | |
| Domain | FILAMIN_REPEAT | 1.27e-04 | 11 | 29 | 2 | PS50194 | |
| Domain | Ig_E-set | 1.13e-02 | 104 | 29 | 2 | IPR014756 | |
| Pathway | WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS | 1.79e-04 | 13 | 22 | 2 | MM15819 | |
| Pathway | WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS | 2.09e-04 | 14 | 22 | 2 | M39614 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 3.12e-04 | 17 | 22 | 2 | MM15861 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 3.12e-04 | 17 | 22 | 2 | M39511 | |
| Pubmed | 4.10e-05 | 225 | 30 | 4 | 12168954 | ||
| Pubmed | 1.49e-04 | 963 | 30 | 6 | 28671696 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.90e-04 | 1451 | 30 | 7 | 30550785 | |
| Pubmed | 4.40e-04 | 418 | 30 | 4 | 34709266 | ||
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 9.33e-08 | 200 | 30 | 6 | M7525 | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.33e-07 | 97 | 30 | 4 | 031bc124739541b0b2591e1b6ef41f12adfd5c18 | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.33e-07 | 97 | 30 | 4 | 0cd19f619f10a35d3107518aa83c0eda0572930a | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Gja1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.33e-07 | 97 | 30 | 4 | 33330ac2de9e49d78b478f175068999235c9af25 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.49e-07 | 112 | 30 | 4 | 1c0bcc6c972c50a9d950cd56b65efb8d778ec25a | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.49e-07 | 112 | 30 | 4 | e30cd0b7b755c63081bbeed4e1a884b6640d34f8 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.94e-06 | 134 | 30 | 4 | a632d78890fcc20db81d2cf6b299470706d2e182 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.94e-06 | 134 | 30 | 4 | 8be2db71d9d29f9a57a64efdc89cf8c3e32b363b | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.59e-06 | 144 | 30 | 4 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 189 | 30 | 4 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 67 | 30 | 3 | 8502da9042f40e0a44354776bb507e18ef0cda43 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 67 | 30 | 3 | e6d051404f095ab9ca95fa6e5ecf0905573a5a63 | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Htra1_(Htra1)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.25e-05 | 67 | 30 | 3 | 3a3a3e76f67c1d33bd7b1d0d94c522ad1e1192f8 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 82 | 30 | 3 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 82 | 30 | 3 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.29e-05 | 82 | 30 | 3 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-05 | 86 | 30 | 3 | c1181a7e9f4cbde5a3bee7b54d6448dfce58b238 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-05 | 86 | 30 | 3 | 4263673abf183f2e04f1a2bf37e365a25b8cb0b4 | |
| ToppCell | Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Htra1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-05 | 86 | 30 | 3 | c6c0e8e562ffc705e0cd3f503a9e43ca2669e9b0 | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.65e-05 | 104 | 30 | 3 | bf27bc52f440d1e94108b35ad85ed593201164c9 | |
| ToppCell | Frontal_cortex-Macroglia-ASTROCYTE-Gja1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.65e-05 | 104 | 30 | 3 | 10e6c5b63c28d8c47e89ab130a7daf01700dd4e4 | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.31e-05 | 121 | 30 | 3 | 8334a6b2ced1d6a4808458d6d4232d1b688ba28a | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.31e-05 | 121 | 30 | 3 | 4b33eeed7b70da120133b14d42c104d2461d52dc | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.31e-05 | 121 | 30 | 3 | a33e4ae0b0efb702db1b646ac0486e3b6ce48457 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 148 | 30 | 3 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 167 | 30 | 3 | 4e58f9bf1e9d47720c871776ec34513ded4de9b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 167 | 30 | 3 | 4ae9f2c5df13463709ea880ab035965fd99e7626 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.93e-04 | 168 | 30 | 3 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 2.00e-04 | 170 | 30 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 171 | 30 | 3 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-04 | 171 | 30 | 3 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 177 | 30 | 3 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.25e-04 | 177 | 30 | 3 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 182 | 30 | 3 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 184 | 30 | 3 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 185 | 30 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 30 | 3 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 30 | 3 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 30 | 3 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.64e-04 | 187 | 30 | 3 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | e5325f1c7430b574947f8ee67e425455b60dc518 | |
| ToppCell | droplet-Lung-nan-18m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | ca657353f2b649530809c0bc057e448adc511ec1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 199 | 30 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.17e-04 | 199 | 30 | 3 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 3.22e-04 | 200 | 30 | 3 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 3.22e-04 | 200 | 30 | 3 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 3.22e-04 | 200 | 30 | 3 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 3.22e-04 | 200 | 30 | 3 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| Disease | level of Phosphatidylethanolamine (16:0_18:2) in blood serum | 1.53e-06 | 24 | 28 | 3 | OBA_2045136 | |
| Disease | protein-tyrosine sulfotransferase 2 measurement | 2.42e-05 | 8 | 28 | 2 | EFO_0801971 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 7.85e-05 | 14 | 28 | 2 | OBA_2045142 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 9.05e-05 | 15 | 28 | 2 | OBA_2045165 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 1.03e-04 | 16 | 28 | 2 | OBA_2020007 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.80e-04 | 21 | 28 | 2 | OBA_2045156 | |
| Disease | triacylglycerol 54:6 measurement | 1.98e-04 | 22 | 28 | 2 | EFO_0010424 | |
| Disease | triacylglycerol 56:4 measurement | 2.37e-04 | 24 | 28 | 2 | EFO_0010431 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 3.23e-04 | 28 | 28 | 2 | OBA_2045139 | |
| Disease | triacylglycerol 54:3 measurement | 3.97e-04 | 31 | 28 | 2 | EFO_0010421 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 4.23e-04 | 32 | 28 | 2 | EFO_0010363 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 5.36e-04 | 36 | 28 | 2 | EFO_0022257 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 7.30e-04 | 42 | 28 | 2 | EFO_0022255 | |
| Disease | free cholesterol to total lipids in IDL percentage | 7.65e-04 | 43 | 28 | 2 | EFO_0022278 | |
| Disease | triacylglycerol 54:4 measurement | 8.76e-04 | 46 | 28 | 2 | EFO_0010422 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.03e-03 | 50 | 28 | 2 | EFO_0022303 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.08e-03 | 51 | 28 | 2 | EFO_0022331 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.08e-03 | 51 | 28 | 2 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.08e-03 | 51 | 28 | 2 | EFO_0022242 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 1.08e-03 | 51 | 28 | 2 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides in HDL measurement | 1.16e-03 | 53 | 28 | 2 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.16e-03 | 53 | 28 | 2 | EFO_0022286 | |
| Disease | triglycerides in medium HDL measurement | 1.21e-03 | 54 | 28 | 2 | EFO_0022321 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.25e-03 | 55 | 28 | 2 | EFO_0022234 | |
| Disease | phospholipids in medium HDL measurement | 1.25e-03 | 55 | 28 | 2 | EFO_0022295 | |
| Disease | triacylglycerol 52:2 measurement | 1.25e-03 | 55 | 28 | 2 | EFO_0010414 | |
| Disease | triglycerides in very large VLDL measurement | 1.30e-03 | 56 | 28 | 2 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.30e-03 | 56 | 28 | 2 | EFO_0022333 | |
| Disease | triglycerides in large VLDL measurement | 1.30e-03 | 56 | 28 | 2 | EFO_0022178 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.30e-03 | 56 | 28 | 2 | EFO_0022316 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.30e-03 | 56 | 28 | 2 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 1.30e-03 | 56 | 28 | 2 | EFO_0022251 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.31e-03 | 229 | 28 | 3 | EFO_0004639, EFO_0008317 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 1.39e-03 | 58 | 28 | 2 | EFO_0022338 | |
| Disease | triglycerides in IDL measurement | 1.39e-03 | 58 | 28 | 2 | EFO_0022149 | |
| Disease | total lipids in medium HDL measurement | 1.39e-03 | 58 | 28 | 2 | EFO_0022310 | |
| Disease | triglycerides in VLDL measurement | 1.44e-03 | 59 | 28 | 2 | EFO_0022326 | |
| Disease | triglycerides to total lipids in small LDL percentage | 1.44e-03 | 59 | 28 | 2 | EFO_0022337 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYISHLGHGVRGAQP | 586 | A9YTQ3 | |
| AIYVAGGVSGGHINP | 71 | O43315 | |
| HTVSVGVGGPESYCH | 146 | Q7LC44 | |
| VEFHVHGGPAVVSGV | 111 | Q969Y2 | |
| HGVYHPGQSSILEGT | 471 | Q8IYT2 | |
| AHYHISPGLQGVGPV | 1151 | Q9BXF3 | |
| SSGEGIGVIGVHPHK | 181 | Q96MT7 | |
| IQHPGGQRVIGHYAG | 51 | O95864 | |
| GSIYHSVEGPLTGHG | 1431 | Q2LD37 | |
| VGGAHEALYSVPGEH | 191 | Q86VF5 | |
| QRLPVVHHYGHGSGG | 296 | Q99489 | |
| GAVHNGKIYISGGVH | 466 | Q9P2G3 | |
| GHVTAYGPGLTHGVV | 1866 | P21333 | |
| GPGVYHHGAIISPAG | 101 | Q6P531 | |
| HAGTVGTLPLGGYVA | 151 | Q99946 | |
| VGAHIPFHVGLYTGE | 616 | Q9UN75 | |
| GTSPEGIGGYIHSHR | 326 | Q8TBX8 | |
| RPTHSYHVGLEGGLG | 206 | Q8N9Y4 | |
| TLHQVIYGAAGHPEG | 146 | P00540 | |
| GPSGEPVVYHGHTLT | 341 | Q9BRC7 | |
| GTVSHAQELGIHPYG | 1141 | Q9Y2K2 | |
| IVVVGFSVYGGGGIH | 1756 | O75592 | |
| TVKLHYVHSTPGGSG | 1221 | Q8IZQ1 | |
| YGAIGVIVGHEFTHG | 571 | P78562 | |
| PVSGGGGTHVTQVHI | 21 | A8MZF0 | |
| GGLIPLHNAASYGHV | 711 | Q9H2K2 | |
| IGVTVHTGTADGGHY | 2151 | Q70CQ2 | |
| PQGHVAVAVGSGGSY | 36 | Q9BWQ6 | |
| VGGIHVVPAGLTYST | 2401 | P15822 | |
| HGPGVEGVTHYKAGD | 26 | O15321 | |
| GVTVAGAYPAGPHTH | 606 | Q14003 |